Hasandalan, Krystal .
HRN: 23-83-73 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/30/2024
AMPICILLIN 500MG (VIAL)
10/30/2024
11/05/2024
IV
400mg
Q6
Pcap
Waiting Final Action
10/30/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/30/2024
11/05/2024
IV
120
OD
Pcap
Waiting Final Action
10/31/2024
CEFUROXIME 1.5GM (VIAL)
10/31/2024
11/06/2024
IV
270mg
Q8
PCAP C
Waiting Final Action